John Armitage's Egerton Capital exited CME Group Inc (CME) during 2026 Q2, according to the 13F-HR filed with the SEC on July 21, 2026, selling all 1.18M shares. The position had been worth about $349.4M at the prior quarter-end and carried 3.88% of the book. CME had been in the portfolio for 1.5 years, since the quarter ended December 31, 2024.
What did the 2026 Q2 filing report for CME?
As of June 30, 2026, from the 13F-HR filed July 21, 2026.
| Before | After | |
|---|---|---|
| Shares | 1.18M | 0 |
| Reported value | $349.4M | $0 |
| Portfolio weight | 3.88% | 0% |
| Held since | 2024 Q4 | sold out in 2026 Q2 |
| Quarters held | 6 |
What did John Armitage sell?
John Armitage sold 1.18M shares of CME between the quarter ended March 31, 2026 and June 30, 2026. The CME exit was the 4th largest of the quarter's 29 position changes by percent change to portfolio.
Where does CME sit in the John Armitage portfolio?
Before the sale, CME carried 3.88% of the John Armitage portfolio, about the fund's average stock position of 4%. The largest stock position is V at 14.13%. Next come GOOG at 11.24% and APH at 8.29%. The three largest stocks together are 33.66% of the book. Across the 2026 Q2 portfolio, John Armitage reported 23 stock positions, with 5 opened and 6 closed. The total portfolio value is about $10.4B, up 15% from the prior quarter.
How long has John Armitage held CME?
John Armitage held CME for 1.5 years, from the quarter ended December 31, 2024 to March 31, 2026. The fund sold out of the name in 2021 Q2 and came back in 2024 Q4. The weight peaked at 5.3% in 2025 Q1. The share count had been unchanged the quarter before. Every reported trade is on the John Armitage CME trade history page.
Did other funds buy or sell CME in 2026 Q2?
Among the other tracked funds that had filed for 2026 Q2 as of July 21, 2026, 7 still hold CME. Meanwhile 3 opened it. The largest buyers of CME this quarter were Lewis Sanders, Seth Klarman and Mairs & Power Growth Fund. The largest sellers were William Von Mueffling and Parnassus Endeavor Fund. Every tracked holder of CME is on the CME ownership page.
FAQ
How many CME shares did John Armitage sell?
John Armitage sold all 1.18M shares of CME it reported a quarter earlier, worth about $349.4M.
When did John Armitage first buy CME?
John Armitage first reported CME in the quarter ended December 31, 2020.
How much of the John Armitage portfolio was CME?
CME was 3.88% of the John Armitage portfolio at the prior quarter-end, and 0% after the sale.
Did other funds sell CME in 2026 Q2?
No other tracked fund sold out of CME in 2026 Q2, but 2 trimmed it; 7 still hold it.